XML 69 R22.htm IDEA: XBRL DOCUMENT v2.4.0.6
SHARE-BASED COMPENSATION SHARE-BASED COMP - (Notes)
12 Months Ended
Dec. 31, 2012
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
STOCK-BASED COMPENSATION:

The fair value of each stock option and SAR award is estimated on the date of grant using a Black-Scholes option pricing model. The Company’s expected volatilities are based on historical volatility of the Company’s common stock.  To the extent that volatility of the Company’s common stock price increases in the future, the estimates of the fair value of stock options and SARs granted in the future could increase, thereby increasing stock-based compensation expense in future periods. Additionally, the expected dividend yield is considered for each grant on the date of grant.  The Company’s uses the simplified method in determining the expected term of stock options and SARs granted, which results in the use of the average midpoint between vesting of the awards and their contractual term for such estimate.  The Company utilizes the simplified method primarily because it has experienced several acquisitions and divestitures during the contractual period for the current awards outstanding, resulting in a change in the employee mix and an acceleration of certain stock option and SAR exercise activity.  Additionally, the Company has not experienced a full life cycle of exercise activity for employees associated with certain of its acquisitions.  Because of the impact of these significant structural changes in the Company’s business operations and the resulting variations in employee exercise activity, the historical patterns of such exercise activity is not believed to be indicative of future behavior.  In the future, as information regarding post-vesting termination becomes more accessible, the Company may change the method of deriving the expected term.  This change could impact the fair value of stock options and SARs granted in the future.  The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant.

All outstanding stock awards vested and were settled in 2012 in connection with the ETE Merger on March 26, 2012; therefore, no 2012 amounts have been presented in the following sections.

The following table represents the Black-Scholes estimated ranges under the Company’s plans for stock options and SARs awards granted in the periods presented:

 
 
Years ended December 31,
 
 
2011
 
2010
Expected volatility
 
32.83% to 35.60%
 
32.79% to 34.98%
Expected dividend yield
 
2.45%
 
2.45% to 2.47%
Risk-free interest rate
 
1.58% to 2.41%
 
1.78% to 2.40%
Expected life
 
4.75 to 6 years
 
4.75 to 6 years


Stock Options

The following table provides information on stock options granted, exercised, forfeited, outstanding and exercisable under the Third Amended and Restated 2003 Stock and Incentive Plan (Third Amended 2003 Plan) and the 1992 Long-Term Stock Incentive Plan (1992 Plan) for the periods presented:

 
 
Third Amended 2003 Plan
 
1992 Plan
 
 
Shares
Under
Option
 
Weighted-
Average
Exercise
Price
 
Shares
Under
Option
 
Weighted-
Average
Exercise
Price
Outstanding December 31, 2009
 
3,014,220

 
$
20.69

 
49,019

 
$
14.65

Granted
 
684,635

 
24.90

 

 

Exercised
 
(91,044
)
 
19.48

 
(9,860
)
 
14.65

Forfeited
 
(10,940
)
 
25.60

 

 

Outstanding December 31, 2010
 
3,596,871

 
21.51

 
39,159

 
$
14.65

Granted
 
75,271

 
28.49

 

 

Exercised
 
(77,386
)
 
17.22

 
(29,188
)
 
14.65

Forfeited
 
(510
)
 
24.06

 
(9,971
)
 
14.65

Outstanding December 31, 2011
 
3,594,246

 
21.75

 

 
$

 
 
 
 
 
 
 
 
 
Exercisable December 31, 2010
 
1,814,539

 
$
19.83

 
39,159

 
$
14.65

Exercisable December 31, 2011
 
2,478,000

 
19.86

 

 



The following table summarizes information about stock options outstanding under the Third Amended 2003 Plan at December 31, 2011.

 
 
Options Outstanding
 
Options Exercisable
Range of Exercise Prices
 
Number of Options
 
Weighted-Average Remaining Contractual Life
 
Weighted-Average Exercise Price
 
Number of Options
 
Weighted-Average Exercise Price
Third Amended 2003 Plan:
 
 
 
 
 
 
 
 
 
 
12.55 - 15.00
 
792,934

 
6.96 years
 
$
12.55

 
792,934

 
$
12.55

15.01 - 20.00
 
205,573

 
4.78 years
 
16.90

 
205,573

 
16.90

20.01 - 25.00
 
1,726,790

 
7.00 years
 
23.28

 
1,127,284

 
23.04

25.01 - 28.49
 
868,949

 
6.47 years
 
28.23

 
352,209

 
27.85

 
 
3,594,246

 
6.73 years
 
$
21.75

 
2,478,000

 
$
19.86



Stock Appreciation Rights

The following table provides information on SARs granted, exercised, forfeited, outstanding and exercisable under the Third Amended 2003 Plan for the periods presented.

 
 
Third Amended 2003 Plan
 
 
SARs
 
Weighted-Average
Exercise Price
Outstanding December 31, 2009
 
1,493,131

 
$
19.18

Granted
 
376,795

 
24.67

Exercised
 
(47,322
)
 
12.64

Forfeited
 
(38,648
)
 
19.93

Outstanding December 31, 2010
 
1,783,956

 
$
20.50

Granted
 
4,276

 
28.10

Exercised
 
(77,477
)
 
15.33

Forfeited
 
(47,415
)
 
25.33

Outstanding December 31, 2011
 
1,663,340

 
$
20.63

 
 
 
 
 
Exercisable December 31, 2010
 
900,965

 
$
20.53

Exercisable December 31, 2011
 
1,278,950

 
19.71



The SARs that have been awarded vest in equal installments on the first three anniversaries of the grant date.  Each SAR entitles the holder to shares of Southern Union’s common stock equal to the fair market value of Southern Union’s common stock on the applicable exercise date in excess of the grant date price for each SAR.

The following table summarizes information about SARs outstanding under the Third Amended 2003 Plan at December 31, 2011.

 
 
SARs Outstanding
 
SARs Exercisable
Range of Exercise Prices
 
Number of SARs
 
Weighted-Average Remaining Contractual Life
 
Weighted-Average Exercise Price
 
Number of SARs
 
Weighted-Average Exercise Price
12.55 - 17.50
 
568,685

 
6.96 years
 
$
12.55

 
568,685

 
$
12.55

17.51 - 25.00
 
745,401

 
8.44 years
 
23.17

 
365,287

 
22.68

25.01 - 28.48
 
349,254

 
5.71 years
 
28.35

 
344,978

 
28.36

 
 
1,663,340

 
7.36 years
 
$
20.63

 
1,278,950

 
$
19.71



The weighted-average remaining contractual life of options and SARs outstanding under the Third Amended 2003 Plan at December 31, 2011 was 6.93 years.  The weighted-average remaining contractual life of options and SARs exercisable under the Third Amended 2003 Plan at December 31, 2011 was 6.56 years.  The aggregate intrinsic value of total options and SARs outstanding and exercisable at December 31, 2011 was $109 million and $84 million, respectively.

The total fair value of options and SARs vested as of December 31, 2011 was $22 million.  Compensation expense recognized related to stock options and SARs totaled $7 million and $6 million for the years ended December 31, 2011 and 2010, respectively.  Cash received from the exercise of stock options was $2 million for the year ended December 31, 2011.

The intrinsic value of options and SARs exercised during the year ended December 31, 2011 was approximately $2 million.  The Company realized an additional tax benefit of less than $1 million for the excess amount of deductions related to stock options and SARs over the historical book compensation expense multiplied by the statutory tax rate in effect, which has been reported as an increase in financing cash flows in the consolidated statement of cash flows.

Restricted Stock Equity and Liability Units

The Company’s Third Amended 2003 Plan also provides for grants of restricted stock equity units, which are settled in shares of the Company’s common stock, and restricted stock liability units, which are settled in cash.  The restrictions associated with a grant of restricted stock equity units under the Third Amended 2003 Plan generally expire equally over a period of three years.  Restrictions on certain grants made to non-employee directors and senior executives of the Company expire over a shorter time period, in certain cases less than one year, and may be subject to accelerated expiration over a shorter term if certain criteria are met.  The restrictions associated with a grant of restricted stock liability units expire equally over a period of three years and are payable in cash at the vesting date.

The following table provides information on restricted stock equity awards granted, released and forfeited for the periods presented.

 
 
Number of
Restricted Stock
Equity Units
Outstanding
 
Weighted-Average
Grant Date
Fair Value
Restricted shares at December 31, 2009
 
378,974

 
$
19.14

Granted
 
111,457

 
23.71

Released
 
(148,218
)
 
17.63

Forfeited
 
(1,000
)
 
25.15

Restricted shares at December 31, 2010
 
341,213

 
$
21.27

Granted
 
7,000

 
28.04

Released
 
(162,362
)
 
17.96

Forfeited
 

 

Restricted shares at December 31, 2011
 
185,851

 
$
24.41



The following table provides information on restricted stock liability awards granted, released and forfeited for the periods presented.

 
 
Number of
Restricted Stock Liability Units Outstanding
 
Weighted-Average
Grant Date
Fair Value
Restricted units at December 31, 2009
 
563,650

 
$
18.38

Granted
 
175,043

 
24.67

Released
 
(237,219
)
 
18.82

Forfeited
 
(54,344
)
 
18.77

Restricted units at December 31, 2010
 
447,130

 
$
20.56

Granted
 
270,835

 
42.01

Released
 
(239,714
)
 
18.53

Forfeited
 
(17,394
)
 
18.86

Restricted units at December 31, 2011
 
460,857

 
$
34.29



The total fair value of restricted stock equity and liability units that were released during the year ended December 31, 2011 was $13 million. Compensation expense recognized related to restricted stock equity and liability units totaled $14 million and $9 million for the years ended December 31, 2011 and 2010, respectively.

The Company settled the restricted stock liability units released in 2011 and 2010 with cash payments of $10 million and $6 million, respectively.